Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association between age and efficacy of first-line immunotherapy-based combination therapies for mRCC: a meta-analysis.
Yanagisawa T, Quhal F, Kawada T, Bekku K, Laukhtina E, Rajwa P, Deimling MV, Chlosta M, Pradere B, Karakiewicz PI, Mori K, Kimura T, Schmidinger M, Shariat SF. Yanagisawa T, et al. Among authors: chlosta m. Immunotherapy. 2023 Oct;15(15):1309-1322. doi: 10.2217/imt-2023-0039. Epub 2023 Sep 11. Immunotherapy. 2023. PMID: 37694583 Review.
Role of clinicopathological variables in predicting recurrence and survival outcomes after surgery for non-metastatic renal cell carcinoma: Systematic review and meta-analysis.
Majdoub M, Yanagisawa T, Quhal F, Laukhtina E, von Deimling M, Kawada T, Rajwa P, Bianchi A, Pallauf M, Mostafaei H, Chlosta M, Pradere B, Karakiewicz PI, Schmidinger M, Rub R, Shariat SF. Majdoub M, et al. Among authors: chlosta m. Int J Cancer. 2024 Apr 1;154(7):1309-1323. doi: 10.1002/ijc.34793. Epub 2023 Nov 27. Int J Cancer. 2024. PMID: 38009868
The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non-muscle-invasive bladder cancer: A network meta-analysis.
Kawada T, Yanagisawa T, Bekku K, Laukhtina E, von Deimling M, Chlosta M, Pradere B, Teoh JY, Babjuk M, Araki M, Shariat SF. Kawada T, et al. Among authors: chlosta m. Urol Oncol. 2023 Jun;41(6):261-273. doi: 10.1016/j.urolonc.2023.04.003. Epub 2023 May 2. Urol Oncol. 2023. PMID: 37137745 Free article. Review.
Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis.
Yanagisawa T, Kawada T, Quhal F, Bekku K, Laukhtina E, Rajwa P, von Deimling M, Majdoub M, Chlosta M, Pradere B, Mori K, Kimura T, Schmidinger M, Karakiewicz PI, Shariat SF. Yanagisawa T, et al. Among authors: chlosta m. World J Urol. 2023 Jul;41(7):1763-1774. doi: 10.1007/s00345-023-04412-0. Epub 2023 May 20. World J Urol. 2023. PMID: 37209143 Free PMC article.
Repeat Transurethral Resection for Non-muscle-invasive Bladder Cancer: An Updated Systematic Review and Meta-analysis in the Contemporary Era.
Yanagisawa T, Kawada T, von Deimling M, Bekku K, Laukhtina E, Rajwa P, Chlosta M, Pradere B, D'Andrea D, Moschini M, Karakiewicz PI, Teoh JY, Miki J, Kimura T, Shariat SF. Yanagisawa T, et al. Among authors: chlosta m. Eur Urol Focus. 2024 Jan;10(1):41-56. doi: 10.1016/j.euf.2023.07.002. Epub 2023 Jul 24. Eur Urol Focus. 2024. PMID: 37495458 Free article. Review.
Survival outcomes of patients treated with local therapy for nonmetastatic prostate cancer with high prostate-specific antigen concentrations.
Ślusarczyk A, Baboudjian M, Zapała P, Yanagisawa T, Miszczyk M, Chlosta M, Krumpoeck P, Moschini M, Gandaglia G, Ploussard G, Rivas JG, Życzkowski M, Karakiewicz PI, Radziszewski P, Leapman MS, Shariat SF, Rajwa P. Ślusarczyk A, et al. Among authors: chlosta m. Prostate. 2023 Nov;83(15):1504-1515. doi: 10.1002/pros.24609. Epub 2023 Aug 7. Prostate. 2023. PMID: 37545342
29 results